Cargando…
Targeting the SARS-CoV-2 3CL(pro) and NO/cGMP/PDE5 pathway in COVID-19: a commentary on PDE5 inhibitors
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Future Medicine Ltd
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885524/ https://www.ncbi.nlm.nih.gov/pubmed/33576273 http://dx.doi.org/10.2217/fca-2020-0201 |